CAM
TMO icon

Crestone Asset Management’s Thermo Fisher Scientific TMO Stock Holding History

Crestone Asset Management’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-335
Closed -$224K – 96
2021
Q4 		$224K Buy
+335
New +$209K 0.05% 85

Other funds holding TMO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Crestone Asset Management's TMO Position: Q1 2022 in Review

Crestone Asset Management sold out of Thermo Fisher Scientific (TMO) in Q1 2022, closing a stake of 335 shares — an estimated $224K sold.

Crestone Asset Management first reported a position in TMO in Q4 2021 and held it in 1 quarter. The position peaked at $224K in Q4 2021. 2,314 funds tracked by Wall St. Rank hold TMO as of Q1 2022.

  • Crestone Asset Management reported no remaining Thermo Fisher Scientific position as of Q1 2022 after selling out during the quarter.
  • Crestone Asset Management sold 335 Thermo Fisher Scientific shares in Q1 2022, an estimated $224K.
  • Crestone Asset Management first reported a position in Thermo Fisher Scientific in Q4 2021 and held it in 1 quarter.
  • Crestone Asset Management's Thermo Fisher Scientific position peaked at $224K in Q4 2021.
  • 2,314 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2022.

Based on Crestone Asset Management's 13F filing for Q1 2022, filed 20 Apr 2022.